BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
SIRT1
,
T cell differentiation
,
Obesity
,
Hypothalamus
,
Holistic medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
retinoid X receptor binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Medulla oblongata
Substantia nigra
Hypothalamus
Vestibular nuclei superior
Amygdala
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Abscess
Weaver syndrome
Hemorrhagic shock
Disease due to Enterovirus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
niguldipine
CGP 60474
VX-745
A 443654
pazopanib
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Ar
MIR122
ANKRD2
NRF1
CLCN2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Dicer1 knockout gene expression during Schwann cell development
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
MicroRNA repsonse to intraperitoneal lipopolysaccharide (LPS) injection
L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA.
The Strategy of Targeting Peroxisome Proliferator-Activated Receptor (PPAR) in the Treatment of Neur…
Utilizing systems biology to reveal cellular responses to peroxisome proliferator-activated receptor…
The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer's Disease and Ot…
ANGPTL4 mediates the protective role of PPARγ activators in the pathogenesis of preeclampsia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Ind…
Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ